ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 768,38
-0,19%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. iTeos Therapeutics Inc (ITOS)

  7. iTeos Therapeutics Inc (ITOS) Actualités

ITOS iTeos Therapeutics Inc

11,66
0,17 (1,48%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
iTeos Therapeutics Inc ITOS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,17 1,48% 11,66 06:00:12
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
11,72 11,51 11,92 11,66 11,49
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/4/202422:30GLOBEiTeos Presents EOS-984 Preclinical Data Demonstrating..
09/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202413:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202413:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:01GLOBEiTeos Appoints Oncology Veteran Jill DeSimone to Its Board..
06/3/202413:00GLOBEiTeos Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202422:30GLOBEiTeos to Highlight Preclinical Data on First-In-Class..
01/3/202413:00GLOBEiTeos to Participate in Upcoming Investor Conferences
10/1/202423:00EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEiTeos Announces 2024 Strategic Priorities and Anticipated..
03/1/202413:00GLOBEiTeos to Present at the 42nd Annual J.P. Morgan Healthcare..
08/12/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202322:11EDGAR2Form 8-K - Current report
21/11/202313:00GLOBEiTeos to Present at the Piper Sandler 35th Annual Healthcare..
07/11/202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:00GLOBEiTeos Reports Third Quarter 2023 Financial Results and..
12/10/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:55PRNUSNCR Atleos Set to Join S&P SmallCap 600
06/9/202313:00GLOBEiTeos to Participate in Upcoming Investor Conferences
08/8/202313:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:00GLOBEiTeos Reports Second Quarter 2023 Financial Results and..
10/5/202313:01GLOBEiTeos Reports First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
ITOS
iTeos Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés